Skip to main content

Table 1 Demographic and clinical characteristics of patients at ICU admission. Risk factors of developing one VAP (univariate analysis, Fine–Gray model considering death and extubation as competing risk events)

From: Epidemiology and microbiology of ventilator-associated pneumonia in COVID-19 patients: a multicenter retrospective study in 188 patients in an un-inundated French region

  All patients No VAP At least one VAP sHR [95%CI], p-value
Headcount 188 96 92  
Baseline and demographic
Mean age (± SD)—years 63.9 (± 11.4) 62.5 (± 12.9) 65.3 (± 9.5) 1.01 [0.99–1.03], p = 0.170
Male—no. (%) 147 (78.2) 67 (69.8) 80 (87) 2.12 [1.14–3.96], p = 0.018
Obesity—no./total no. (%) 69/182 (37.9) 40/92 (43.5) 29/90 (32.2) 0.67 [0.40–1.12], p = 0.130
Hypertension—no. (%) 90 (47.9) 47 (49) 43 (46.7) 0.95 [0.64–1.43], p = 0.820
Diabetes—no. (%) 50 (26.6) 25 (26) 25 (27.2) 0.96 [0.62–1.49], p = 0.860
Current smoker—no. (%) 10 (5.6) 7 (7.3) 3 (3.3) -
Asthma—no. (%) 13 (6.9) 6 (6.2) 7 (7.6) Known respiratory disease
1.39 [0.81, 2.41], p = 0.240
COPD—no. (%) 6 (3.2) 1 (1) 5 (5.4)
OSAS—no. (%) 9 (4.8) 5 (5.2) 4 (4.3)
Pulmonary emphysema—no. (%) 4 (2.1) - 4 (4.3)
Interstitial lung disease—no. (%) 3 (1.6) 1 (1) 2 (2.2)
Cirrhosis—no. (%) 3 (1.6) 2 (2.1) 1 (1.1) -
Chronic kidney failure—no. (%) 8 (4.3) 6 (6.2) 2 (2.2) -
Chronic heart failure—no. (%) 13 (6.9) 8 (8.3) 5 (5.4) -
Cancer—no. (%) 11 (5.9) 5 (5.2) 6 (6.5) -
Hematologic malignancies—no. (%) 5 (2.7) 4 (4.2) 1 (1.1) Immunocompromised status
0.68 [0.32, 1.43], p = 0.310
HIV infection—no. (%) 4 (2.1) 2 (2.1) 2 (2.2)
Immunosuppressive therapy—no. (%) 7 (3.7) 3 (3.1) 4 (4.3)
Long-term corticosteroid therapy—no. (%) 3 (1.6) 2 (2.1) 1 (1.1)
On arrival in the ICU
Mean SAPS II (± SD) 41 (± 13.5) 41.1 (± 13.8) 40.9 (± 13.3) 1.00 [0.98–1.01], p = 0.700
Mean SOFA (± SD) 5.8 (± 2.7) 5.8 (± 2.7) 5.7 (± 2.7) 1.00 [0.92–1.09], p = 0.960
Mean PaO2/FiO2 (± SD)—mmHg 150 (± 63.4) 150 (± 63.6) 150 (± 63.6) 1.00 [1.00–1.00], p = 0.850
  1. ICU, intensive care unit; VAP, ventilator-associated pneumonia; sHR, sub-hazards ratio; CI, confidence interval; SD, standard deviation; COPD, chronic obstructive pulmonary disease; OSAS, obstructive sleep apnea syndrome; HIV, Human Immunodeficiency Virus; SAPS II, Simplified Acute Physiology Score II; SOFA, sepsis-related organ failure assessment; PaO2, arterial partial pressure of oxygen; FiO2, fraction of inspired oxygen